Biogen推进阿尔茨海默症药物至晚期试验——尽管数据令人失望但最低剂量显示tau蛋白降低信号

Biogen推进阿尔茨海默症药物至晚期试验——尽管数据令人失望但最低剂量显示tau蛋白降低信号

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest…